General Information of Drug (ID: DMQDUG4)

Drug Name
ISIS-CRP Drug Info
Synonyms
1-(Tert-butyl)-3-(4-chlorophenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine; 172889-27-9; pp2; PP 2; 1-(tert-butyl)-3-(4-chlorophenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine; AG 1879; 1-tert-butyl-3-(4-chlorophenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine; PP2; 4-Amino-5-(4-chlorophenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine; AG-1879; CHEMBL406845; CHEBI:78331; AK-60369; 1-tert-butyl-3-(4-chlorophenyl)pyrazolo[3,4-d]pyrimidin-4-amine; 3-(4-chlorophenyl) 1-(1,1-dimethylethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine; C15H16ClN5; 1qpe; 4few; PBBRWFOVCUAONR-UHFFFAOYSA-N; AG1879; PP 2 (AG 1879)
Cross-matching ID
TTD Drug ID
D06CIJ

Consensus Signature of Drug Pharmacogenomic Perturbation (DPP)

Term Name NES FDR q-val Tag % Leading Edge Genes
Ether lipid metabolism 2.11 0.00e+0 32/49 (65.31%) PLPP3;ENPP2;PLPP1;...
Metabolism of xenobiotics by cytochrome P450 1.96 8.49e-3 49/77 (63.64%) EPHX1;CYP1B1;AKR1C1;...
Histidine metabolism 1.88 1.13e-2 16/22 (72.73%) HNMT;ALDH2;MAOB;...
Tryptophan metabolism 1.87 8.49e-3 35/42 (83.33%) CYP1B1;ALDH2;MAOB;...
Sulfur metabolism 1.86 8.49e-3 9/10 (90%) SELENBP1;MPST;TST;...
Glycerolipid metabolism 1.83 1.13e-2 44/61 (72.13%) PLPP3;PLPP1;ALDH2;...
Steroid hormone biosynthesis 1.83 9.71e-3 43/61 (70.49%) AKR1C3;CYP1B1;AKR1C2;...
Other glycan degradation 1.81 1.49e-2 13/18 (72.22%) FUCA1;HEXA;HEXB;...
Peroxisome 1.71 4.06e-2 72/82 (87.8%) SOD2;IDH1;CAT;...
Complement and coagulation cascades 1.68 4.59e-2 76/85 (89.41%) C1R;C1S;CFB;...
IL-17 signaling pathway -1.67 4.31e-2 84/94 (89.36%) CCL2;IL1B;SRSF1;...
Renal cell carcinoma -1.72 3.06e-2 68/69 (98.55%) PIK3CD;KRAS;PIK3CB;...
Legionellosis -1.77 1.71e-2 51/57 (89.47%) CXCL2;SAR1A;IL1B;...
Tight junction -1.77 1.83e-2 130/169 (76.92%) CD1A;CD1C;PPP2R1B;...
Colorectal cancer -1.78 1.88e-2 84/86 (97.67%) LEF1;BAK1;GRB2;...
Epithelial cell signaling in Helicobacter pylori infect... -1.79 1.63e-2 62/70 (88.57%) IKBKG;ATP6V0E1;CXCL2;...
Thyroid cancer -1.81 1.56e-2 36/37 (97.3%) NCOA4;LEF1;BAK1;...
Prion disease -1.82 1.34e-2 209/273 (76.56%) SEM1;NDUFS6;PIK3CB;...
Yersinia infection -1.90 6.79e-3 120/137 (87.59%) CCL2;IL1B;MYD88;...
Salmonella infection -1.97 0.00e+0 198/249 (79.52%) TUBB1;IL1B;MYL12B;...
Steroid biosynthesis -2.03 0.00e+0 19/20 (95%) LBR;DHCR7;SOAT2;...
Bladder cancer -2.07 0.00e+0 40/41 (97.56%) KRAS;CDK4;E2F3;...
Ribosome biogenesis in eukaryotes -2.12 0.00e+0 52/108 (48.15%) NXF3;RCL1;REXO2;...
Proteasome -2.15 0.00e+0 44/46 (95.65%) PSME3;PSMB5;PSMC6;...
Bacterial invasion of epithelial cells -2.17 0.00e+0 59/77 (76.62%) PIK3CD;CTNNA3;PIK3CB;...
Spliceosome -2.24 0.00e+0 101/150 (67.33%) LSM5;FUS;DDX5;...
RNA transport -2.25 0.00e+0 128/186 (68.82%) ELAC2;RAE1;NUP188;...
×

Pharmacogenomic Perturbation Across Diseases and Tissues

Breast
Breast adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
MCF7 CVCL_0031 Homo sapiens 10uM 6H, 24H
Colon
Colorectal adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HT-29 CVCL_0320 Homo sapiens 10uM 6H
Fibroblast
Nasopharyngeal carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
FIBRNPC CVCL_UK07 Homo sapiens 10uM 6H, 24H
Hematopoietic system
Normal
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
ASC CVCL_U602 Homo sapiens 10uM 24H
Kidney
Normal (Immortalized)
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HA1E CVCL_0284 Homo sapiens 10uM 6H, 24H
Liver
Hepatoblastoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
Hep G2 CVCL_0027 Homo sapiens 10uM 6H
Lung
Lung adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A549 CVCL_0023 Homo sapiens 10uM 6H, 24H
Non-small cell lung carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HCC515 CVCL_5134 Homo sapiens 10uM 6H, 24H
Prostate
Prostate carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
PC-3 CVCL_0035 Homo sapiens 10uM 6H, 24H
VCaP CVCL_2235 Homo sapiens 10uM 6H, 24H
Skin
Melanoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A-375 CVCL_0132 Homo sapiens 10uM 6H